Fei Ren

Title: Fei Ren: Innovator in Asthma Treatment

Introduction

Fei Ren is a notable inventor based in Macao, CN, recognized for his contributions to the field of respiratory medicine. His innovative work focuses on the use of ganoderma fungal RNA molecules in developing new treatments for asthma. With a single patent to his name, he is making strides in the pharmaceutical industry.

Latest Patents

Fei Ren holds a patent titled "Use of ganoderma fungal RNA molecules, drug, drug composition and delivery carrier." This patent presents a groundbreaking approach to asthma treatment by utilizing tRFs derived from traditional Chinese medicine. The research demonstrates that these RNA molecules have a significant inhibitory effect on airway smooth muscle cell phenotype changes induced by TGF-β1, as well as inflammation and remodeling in asthma mice. The drug comprises the RNA molecule along with a pharmaceutically acceptable carrier, diluent, and/or excipient. This innovation is expected to aid in the development of effective asthma treatment drugs and may provide insights for treating other respiratory diseases.

Career Highlights

Fei Ren is affiliated with the Macau University of Science and Technology, where he conducts research and develops innovative solutions for respiratory health. His work is characterized by a commitment to advancing medical science and improving patient outcomes.

Collaborations

Fei Ren collaborates with esteemed colleagues, including Zhihong Jiang and Yuan Ma, to further enhance the research and development of asthma treatments. Their combined expertise contributes to the advancement of knowledge in this critical area of healthcare.

Conclusion

Fei Ren's innovative approach to asthma treatment through the use of ganoderma fungal RNA molecules showcases his dedication to improving respiratory health. His contributions are paving the way for new therapeutic options in the medical field.